Studies reported to date have correlated HMGB1 upregulation with the onset and progression of melanoma, colon cancer, breast cancer, and pancreatic cancer, chiefly pointing towards the role of HMGB1 in augmenting neo-angiogenesis in cancerous tumor [103,104,105]. Here, HMGB1 is linked to pancreatic neoplasm.